Navigation Links
Less HRT, Fewer Cases of Possible Breast Cancer Precursor
Date:11/12/2009

As hormone use declined, so did incidence of abnormal cells in milk ducts, study finds

THURSDAY, Nov. 12 (HealthDay News) -- Declining use of hormone replacement therapy may be driving down rates of a condition called "atypical ductal hyperplasia," a known risk factor for breast cancer, new research suggests.

This is the first time a link has been found between atypical ductal hyperplasia -- abnormal cells in the breast's milk ducts -- and hormone therapy, said Diana Miglioretti, senior author of a paper published in the November issue of Cancer Epidemiology, Biomarkers & Prevention.

"It sounds like another reason not to take hormones," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge.

"This is part of a pattern that combined use of hormone therapy with both estrogen and progesterone does something to a woman's breast that predisposes them to atypical ductal hyperplasia, which is felt to be a precursor to certain types of malignancies," Brooks added.

If atypical ductal hyperplasia does turn out to be a precursor to breast cancer, this link would be a good indicator of how use of hormone therapy -- often used for menopausal symptoms such as hot flashes -- can help spur malignancy.

The findings are in keeping with other recent research showing a decline in breast cancer rates since the release of results from the Women's Health Initiative, a major trial that caused many women to stop taking combined (estrogen plus progesterone) hormone therapy.

The Women's Health Initiative was halted in July of 2002 after researchers found higher risks of heart attacks and breast cancer in women taking the hormone supplements compared with placebo.

Since that time, use of hormone replacement therapy (HRT) has experienced a precipitous decline.

According to experts, women diagnosed with atypical ductal hyperplasia have a three to five times increased risk of developing breast cancer, either in the same breast or the opposite breast.

Atypical ductal hyperplasia "is a benign condition but it is a risk factor for breast cancer. It's not clear if it's a precursor to breast cancer," said Miglioretti, who is a senior investigator with the Group Health Research Institute in Seattle. "This sheds light on more of the breast process, how HRT affects breast cancer."

Miglioretti and her co-authors analyzed almost 2.5 million screening mammographies from samples provided by the Breast Cancer Surveillance Consortium. The mammograms were done between 1996 and 2005.

In 1999, atypical ductal hyperplasia was found in 5.5 per 10,000 mammograms but by 2005 had declined to only 2.4 per 10,000, a drop of more than half. This occurred despite an increase over time of rates of mammography, which tend to pick up the abnormality.

Meanwhile, breast cancer cases in women with atypical ductal hyperplasia declined from 4.3 per 10,000 mammograms in 2003 to 3.3 per 10,000 mammograms in 2005.

And postmenopausal use of hormone therapy dropped from 35 percent to 11 percent.

The study also revealed that cancers associated with atypical ductal hyperplasia tend to be less aggressive, lending support to the theory that less aggressive and more aggressive cancers develop differently, the authors stated.

One breast cancer expert said the new study dovetails with recent trends in breast cancer incidence.

"The finding they report is consistent with [previous] observations that suggested there was a drop in incidence of breast cancer in about 2003 and it coincided with when the Women's Health Initiative reported that estrogen-plus-progesterone use was associated with an increased risk of heart attacks as well as a slight increased incidence of breast cancer risk," said Dr. James Liu, chairman of obstetrics and gynecology at MacDonald Women's Hospital, Case Medical Center, University Hospitals in Cleveland. "The association caused many women to either question their need to be on [hormone therapy] or stopping it."

But, cautioned Liu, "the data is not strong enough to say this observation was caused by [a decline in hormone use] but it is a very strong association."

More information

There's more on hormone therapy and cancer at the U.S. National Cancer Institute.



SOURCES: Diana Miglioretti, Ph.D., senior investigator, Group Health Research Institute, Seattle; Jay Brooks, M.D., chairman, hematology/oncology, Ochsner Health System, Baton Rouge, La.; James Liu, M.D., chairman, department of obstetrics and gynecology, MacDonald Women's Hospital, Case Medical Center, University Hospitals, Cleveland; November 2009, Cancer Epidemiology, Biomarkers & Prevention


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study
2. Fewer adverse cardiac events at one year
3. Hispanics Receive Fewer Surgeries for Vascular Disease
4. Fewer Women Getting Mammograms
5. Fewer Children Outgrowing Allergies to Milk, Eggs
6. Rural Residents Get Fewer Organ Transplants: Study
7. Children who have an active father figure have fewer psychological and behavioral problems
8. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
9. Fewer Steps Per Day Send Disease Markers Up
10. Breast Cancer Radiation Therapy Works in Fewer, But Higher Doses
11. Overweight kids have fewer cavities, new study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for all ... many other applications. Users can pick and choose from hand-crafted trend-setting designs ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced today ... program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017 Absorption Systems, a global leader in ... pleased to announce that its Chief Operating Officer, ... winner of the 2017 Executive Management Award. The award ... driven executives for their creative management vision, leadership philosophy, ... and celebration is on March 8, 2017 at the ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company, today announced that executive management will participate ... be held February 22-23, 2017. Adrian Adams , ... Company at 1:35 p.m. local time on Wednesday, February ... archive for the event may be accessed from the ...
(Date:2/16/2017)... Summary Provides understanding and access to ... leading healthcare companies. ... Description The Global Allergy Partnering Terms and Agreements since 2010 ... into by the world,s leading healthcare companies. - ... - Deals listed by company A-Z, industry sector, stage of development, ...
Breaking Medicine Technology: